SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+15.8%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$279M
AUM Growth
+$279M
(+7.1%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
30.11%
Holding
75
New
11
Increased
17
Reduced
27
Closed
12
Top Buys
| 1 |
HCA Healthcare
HCA
|
$7.65M |
| 2 |
AET
Aetna Inc
AET
|
$7.1M |
| 3 |
Universal Health Services
UHS
|
$7.03M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.75M |
| 5 |
Cardinal Health
CAH
|
$3.24M |
Top Sells
| 1 |
Zoetis
ZTS
|
$4.69M |
| 2 |
Cencora
COR
|
$3.92M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$3.86M |
| 4 |
Molina Healthcare
MOH
|
$3.72M |
| 5 |
Stryker
SYK
|
$3.55M |
Sector Composition
| 1 | Healthcare | 91.74% |
| 2 | Financials | 2.55% |
| 3 | Energy | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$248B
| $4.95M | 1.77% |
125,000
-25,000
| -17% | -$989K |
|
27
Thermo Fisher Scientific
TMO
$183B
| $4.88M | 1.74% |
20,000
-10,000
| -33% | -$2.44M |
|
|
GWPH
28
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.75M | 1.7% |
+27,500
| New | +$4.75M |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $4.48M | 1.6% |
50,000
+20,000
| +67% | +$1.79M |
|
30
Bausch Health
BHC
$2.84B
| $4.36M | 1.56% |
170,000
+30,000
| +21% | +$770K |
|
31
Quest Diagnostics
DGX
$20.1B
| $4.32M | 1.54% |
40,000
+10,000
| +33% | +$1.08M |
|
32
Teva Pharmaceuticals
TEVA
$21.5B
| $4.31M | 1.54% |
200,000
-85,000
| -30% | -$1.83M |
|
|
WMGI
33
DELISTED
Wright Medical Group Inc
WMGI
| $4.06M | 1.45% |
140,000
+55,100
| +65% | +$1.6M |
|
34
Sarepta Therapeutics
SRPT
$1.81B
| $4.04M | 1.44% |
25,000
-5,000
| -17% | -$808K |
|
|
LHCG
35
DELISTED
LHC Group LLC
LHCG
| $3.61M | 1.29% |
35,000
| – | – |
|
36
Viatris
VTRS
$12.3B
| $3.48M | 1.24% |
95,000
-65,000
| -41% | -$2.38M |
|
|
ALXN
37
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.48M | 1.24% |
25,000
-5,000
| -17% | -$695K |
|
|
38
Cencora
COR
$57.3B
| $3.46M | 1.23% |
37,500
-42,500
| -53% | -$3.92M |
|
|
39
Cardinal Health
CAH
$35.8B
| $3.24M | 1.16% |
+60,000
| New | +$3.24M |
|
40
Qiagen
QGEN
$10.2B
| $3.22M | 1.15% |
85,000
-30,000
| -26% | -$1.14M |
|
41
McKesson
MCK
$86B
| $2.99M | 1.07% |
22,500
-12,500
| -36% | -$1.66M |
|
42
DexCom
DXCM
$29B
| $2.86M | 1.02% |
20,000
+9,100
| +83% | +$1.3M |
|
43
Incyte
INCY
$17B
| $2.76M | 0.99% |
40,000
-45,000
| -53% | -$3.11M |
|
|
BPMC
44
DELISTED
Blueprint Medicines
BPMC
| $2.73M | 0.98% |
+35,000
| New | +$2.73M |
|
45
Labcorp
LH
$22.8B
| $2.61M | 0.93% |
+15,000
| New | +$2.61M |
|
|
LOXO
46
DELISTED
Loxo Oncology, Inc
LOXO
| $2.56M | 0.91% |
15,000
-5,000
| -25% | -$854K |
|
47
Tenet Healthcare
THC
$16.4B
| $2.42M | 0.86% |
+85,000
| New | +$2.42M |
|
48
Teladoc Health
TDOC
$1.35B
| $2.36M | 0.84% |
+27,360
| New | +$2.36M |
|
49
Haemonetics
HAE
$2.58B
| $2.29M | 0.82% |
+20,000
| New | +$2.29M |
|
|
EVHC
50
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $2.06M | 0.73% |
45,000
| – | – |
|